📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. (2016)

First Author: Wasunna M

Attributed to: Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pntd.0004880

PubMed Identifier: 27627654

Publication URI: http://europepmc.org/abstract/MED/27627654

Type: Journal Article/Review

Volume: 10

Parent Publication: PLoS neglected tropical diseases

Issue: 9

ISSN: 1935-2727